In this report, covers the present scenario (with the base year being 2017) and the growth prospects of global Montelukast Sodium market for 2018-2023.

Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
Montelukast sodium can be classified as two types, such as montelukast sodium smorphous and montelukast sodium crystalline. It can be widely used in pharmaceutical industry. Survey results showed that 72.28% of the montelukast sodium market is tablets, 21.44% is chewable tablet and 6.28% is oral solution, this industry will need more montelukast sodium. So, montelukast sodium has a huge market potential in the future.
Over the next five years, LPI() projects that Montelukast Sodium will register a 12.1% CAGR in terms of revenue, reach US$ 390 million by 2023, from US$ 190 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast Sodium market by product type, application, key manufacturers and key regions.

To calculate the market size, considers value and volume generated from the sales of the following segments:

Segmentation by product type:
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Segmentation by application:
Tablets
Chewable Tablet
Oral Solution

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Morepen Laboratories
Mylan
TAPI
MSN Laboratories
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Jubilant Cadista
Aamorb Pharmaceuticals
Sudarshan Groups
Ortin Laboratories
Vamsi Labs
Adley Group
Medopharm
Hengyuan Pharmaceutical
Arromax Pharmaceutical Technology
Lihe Wuhan New Chemical Materials
Shanghai Huachu Chemical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Montelukast Sodium consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Montelukast Sodium market by identifying its various subsegments.
Focuses on the key global Montelukast Sodium manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Montelukast Sodium with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Montelukast Sodium submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.